Multidisciplinary Perspectives on the Management of Metastatic Colon Cancer

SELF STUDY / ENDURING - ESTIMATED TIME TO COMPLETE ACTIVITY: 55 Minutes

Overview

Participants will review multidisciplinary management of metastatic colon cancer, highlighting systemic therapies, biomarker-driven treatment selection, and the roles of surgery and radiation in curative and palliative settings. Case-based discussions will address surveillance, toxicity management, and patient- and disease-specific factors that guide individualized, team-based care decisions.

Target Audience

This CME initiative was designed for oncologists, surgeons, radiation oncologists, NPs, PAs, pharmacists, nurses, and other healthcare professionals involved in the treatment of patients with cancer.

Learning Objectives

  1. Discuss the role of systemic treatments including chemotherapy and targeted medications in the management of colon cancer.
  2. Identify the roles of local treatments including surgery and radiation in the management of colon cancer.
  3. Describe the patient factors and disease factors to be considered in the multidisciplinary management of oligometastatic colon cancer.
Course summary
Available credit: 
  • 0.75 AMA PRA Category 1 Credit

    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). Horizon CME is accredited by the ACCME to provide continuing medical education for physicians.

    Horizon CME designates this Enduring activity for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Course opens: 
06/12/2026
Course expires: 
06/12/2027
Cost:
$0.00
Rating: 
0

Faculty

Karen Rowan, DNP (Moderator)

Family Nurse Practitioner
Hawai'i Oncology
Honolulu, HI

Karen Rowan is a board-certified Family Nurse Practitioner. She received her Doctor of Nursing Practice (DNP) degree from the University of Hawaiʻi at Mānoa. She also holds an MS in Science and Medical Journalism from Boston University, and an MS in Biology from Northeastern Illinois University. Her clinical interests include cancers of the GI tract, lung cancer, breast cancer, and prostate cancer.

Prior to becoming a nurse practitioner, Karen worked as a high school biology teacher in Illinois, and then as a science writer and editor in New York. She has authored articles on advances in cancer research for the Journal of the National Cancer Institute and other publications. 

She is an Associate Editor for the Hawaiʻi Journal of Health & Social Welfare, and a member of Sigma Theta Tau International Honor Society of Nursing. She has enrolled patients in clinical trials at the UH Cancer Center and is a member of the Cancer Center's working group for trials related to cancer care delivery research and symptom management. She is deeply interested in patient education and communication.


 

Jared Acoba, MD (Speaker)

Chief of Oncology, The Queen’s Medical Center 
Associate Professor, University of
Hawai’i Cancer Center
Honolulu, HI

Dr. Jared Acoba is an Associate Researcher at the University of Hawaiʻi Cancer Center and provides support in both clinical and translational research with a focus on gastrointestinal cancers. His efforts have been in developing (1) clinical trial protocols utilizing novel immunotherapeutic agents for the treatment of gastrointestinal cancers and (2) interventions to reduce racial disparities in cancer treatment.  Dr. Acoba also participates in the NCI oncology research bases and serves as a Multiple-PI of the NCI Community Oncology Research Program Grant for UHCC as a Minority/Underserved Community Site.


Rebecca Sawai, MD (Speaker)

General Surgery
Kaiser Permanante Moanalua Medical Center
Honolulu, HI

Rebecca Sawai was born in St. Paul, Minnesota, and grew up there as well as near Portland, Oregon. After years of braving Minnesota winters, the thought of never shoveling snow again was appealing – and it sparked her interest in working in Hawaii. Once she met her colleagues from Hawaii Permanente Medical Group, she knew she had made the right decision to move here.
 
Dr. Sawai earned her medical degree from the University of Rochester School of Medicine and Dentistry in New York. She completed her residency in general surgery at Oregon Health & Science University Hospital in Portland, and her fellowship in colon and rectal surgery at the Mayo Graduate School of Medicine in Rochester, Minnesota. I'm board-certified in colon and rectal surgery by the American Board of Colon and Rectal Surgery and in general surgery by the American Board of Surgery.
 
Dr. Sawai a member of the American College of Surgeons, the American Society of Colon and Rectal Surgeons, the Pacific Coast Surgical Association, and the Northwest Society of Colon and Rectal Surgeons. She also leads certain quality improvement efforts at Kaiser Permanente Hawaii to ensure their patients receive the highest standard of care.


Michael Roach, MD (Speaker)

Pacific Radiation Oncology, Physician
Cancer Center of Hawaii
Honolulu and Aiea, Hawaii

Dr. Roach is a radiation oncologist at Cancer Center of Hawaii. He serves on the cancer research advisory board and the patient review and monitoring committee at University of Hawaii. Before coming to Hawaii, he was chief of gastrointestinal radiation oncology at Washington University in St. Louis.


Disclosures:

In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, Horizon CME (HCME) ensures that continuing education activities are balanced, independent, objective, and scientifically rigorous. 

All persons in a position to influence the content of an accredited continuing education activity provided by Horizon CME are required to disclose to HCME any relevant financial relationships with ineligible companies within the past 24 months. All reported relevant financial relationships have been mitigated by Horizon CME.

Michael Roach, MD, Karen Rowan, DNP, Rebecca Sawai, MD disclose no relevant financial relationships with any entity producing, marketing, re-selling, or distributing healthcare goods or services consumed by, or used on, patients during the past 24 months.

Available Credit

  • 0.75 AMA PRA Category 1 Credit

    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). Horizon CME is accredited by the ACCME to provide continuing medical education for physicians.

    Horizon CME designates this Enduring activity for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Price

Cost:
$0.00
Please login or register to take this course.

There are no fees for participating and receiving CME credit for this enduring activity. To receive CME credit participants must:

  1. Read the CME/CE information and faculty disclosures.
  2. Participate in the online activity.
  3. Complete the post-test
  4. Submit the evaluation form

DISCLAIMER:

This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

Required Hardware/software

Access to the internet is required.

Supported Browsers:

Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above

Google Chrome 28.0+ for Windows, Mac OS, or Linux

Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux

Safari 6.0+ for Mac OSX 10.7 and above

 

Supported Phones & Tablets:

 Android 4.0.3 and above

iPhone/iPad with iOS 6.1 or above